Leptomycin derivatives

Details Leptomycin derivatives Leptomycin derivatives

2008-11-24

2010-10-19

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07816543

ABSTRACT:
Leptomycin derivatives having a moiety, such as a sulfide or a disulfide, that can conjugate to a cell binding reagent such as an antibody are disclosed. The therapeutic use of such leptomycin derivative conjugates is also described; such conjugates have therapeutic use because they can deliver cytotoxic leptomycin derivatives to a specific cell population in a targeted fashion.

REFERENCES:
patent: 4771070 (1988-09-01), Hokanson et al.
patent: 4792522 (1988-12-01), Nettleton et al.
patent: 7446196 (2008-11-01), Dong et al.
patent: 2003/0162740 (2003-08-01), Wang et al.
patent: 2005/0287155 (2005-12-01), Santi et al.
patent: WO 01/07013 (2001-02-01), None
patent: WO 02/062396 (2002-08-01), None
patent: WO 2005/117894 (2005-12-01), None
patent: WO 2005/117986 (2005-12-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface p. 1-15.
Blattler, W. A., et. al., Drugs to Enhance the Therapeutic Potency of Anticancer Antibodies: Antibody-Drug Conjugates as Tumor-Activated Prodrugs, Anticancer Agents, Frontiers in Cancer Chemotherapy, pp. 317-338, ACS Symposium Series 796, (2001), Chapter 19.
Bumol, T. F., et. al., KS1/4-Davlb, A Monoclonal Antibody-Vinca Alkaloid Conjugate for Site-Directed Therapy of Epithelial Malignancies, Antibody Mediated Delivery Systems, pp. 55-79, (1988).
Chari, R. V. J., et. al., Immunoconjugates Containing Novel Maytansinoids: Promising Anticancer Drugs, Cancer Research, vol. 52, pp. 127-131, (1992).
Chari, R. V. J., et. al., Targeted Delivery of Chemotherapeutics Tumor-Activated Prodrug Therapy, Advanced Drug Delivery Reviews, vol. 31, (1998), pp. 89-104.
Diener, E., et. al., Experimental Application of Target-Specific Immunoconjugates Containing Daunomycin as the Cytocidal Component, Antibody Mediated Delivery Systems, pp. 1-23, (1988).
Dillman, R. O., et. al., Preclinical Trials with Combinations and Conjugates of T101 Monoclonal Antibody and Doxorubicin1, Cancer Research, vol. 46, pp. 4886-4891, (1986).
Endo, N., et, al., In Vitro Cytotoxicity of a Human Serum Albumin-Mediated Conjugate of Methotrexate with Anti-MM46 Monoclonal Antibody, Cancer Research, vol. 47, pp. 1076-1080, (1987).
Garnett, M. C., et. al., An Improved Synthesis of a Methotrexate-Albumin-791T/36 Monoclonal Antibody Conjugate Cytotoxic to Human Osteogenic Sarcoma Cell Lines, Cancer Research, vol. 46, pp. 2407-2412, (1986).
Ghetie, M-A., et. al., Evaluation of Ricin A Chain-Containing Immunotoxins Directed Against CD19 and CD22 Antigens on Normal and Malignant Human B-Cells as Potential Reagents for In Vivo Therapy, Cancer Research, vol. 48, pp. 2610-2617, (1988).
Ghose, T., et. al., Antibody-Directed Drug Targeting in Cancer Therapy, Targeted Drugs, pp. 1-22, (1983), Chapter 1.
Hamamoto, T., et. al., Leptomycins A and B, New Antifungal Antibiotics I. Taxonomy of the Producing Strain and Their Fermentation, Purification and Characterization, The Journal of Antibiotics, vol. 36, No. 6, pp. 639-645, (1983).
Hamann, P. R., et. al., An Anti-CD33 Antibody-Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker, Bioconjugate Chem., (2002), vol. 13, pp. 40-46.
Hinman, L. M., et. al., Preparation and Characterization of Monoclonal Antibody Conjugates of the Calicheamicins: A Novel and Potent Family of Antitumor Antibiotics, Cancer Research, vol. 53, pp. 3336-3342, (1993).
Huang, S-Y., et. al., A Polyethylene Glycol Copolymer for Carrying and Releasing Multiple Copies of Cysteine-Containing Peptides, Bioconjugate Chemistry, (1998), vol. 9, pp. 612-617.
Hurwitz, E., et. al., Soluble Macromolecules as Carriers for Daunorubicin, Journal of Applied Biochemistry, vol. 2, pp. 25-35, (1980).
Kalesse, M., et. al.,, The Chemistry and Biology of the Leptomycin Family, Synthesis, (2002), vol. 8, pp. 981-1003.
Kato, Y., et. al., A Novel Method of Conjugation of Daunomycin with Antibody with a Poly-L-Glutamic Acid Derivative as Intermediate Drug Carrier. An Anti-a-Fetoprotein Antibody-Daunomycin Conjugate, J. Med. Chem., (1984) vol. 27, pp. 1602-1607.
Komiyama, K., et. al., Antitumor Activity of Leptomycin B, The Journal of Antibiotics, vol. 38, No. 3, pp. 427-429, (1985).
Lambert, J. M., et. al., Immunotoxins Containing Single Chain Ribosome-Inactivating Proteins, Immunotoxins, (1988), pp. 175-209.
Lambert, J. M., et. al., Purified Immunotoxins That Are Reactive With Human Lymphoid Cells, The Journal of Biological Chemistry, vol. 260, No. 22, (1985), pp. 12035-12041.
Liu, C., et. al., Eradication of Large Colon Tumor Xenografts By Targeted Delivery of Maytansinoids, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 8618-8623, (1996).
Manabe, Y., et. al., Production of a Monoclonal Antibody-Mitomycin C Conjugate, Utilizing Dextran T-40, and Its Biological Activity, Biochemical Pharmacology, vol. 34, No. 2, pp. 289-291, (1985).
Ohkawa, K., et. al., Evaluation of a Conjugate of Purified Antibodies Against Human AFP-Dextran-Daunorubicin to Human AFP-Producing Yolk Sac Tumor Cell Lines, Cancer Immuno Immunother, (1986), vol. 22, pp. 81-86.
Ojima, I., et. al., Rhodium-Catalyzed Carbonylative Silycarbocyclization (Co-Sicac) of 1,6-Enynes, American Chemical Society, pp. 1, (2001), vol. 78.
Pietersz, G. A., et. al., Antibody-Targeted Drugs for the Therapy of Cancer, Journal of Drug Targeting, (1994), vol. 2, pp. 183-215.
Pietersz, G. A., et. al., The Linkage of Cytotoxic Drugs to Monoclonal Antibodies for the Treatment of Cancer, Bioconjugate Chemistry, (1990), vol. 1, No. 2, pp. 89-95.
Pietersz, G. A., et. al., The use of Anthracycline-Antibody Complexes for Specific Antitumor Activity, Antibody Mediated Delivery Systems, pp. 25-53, (1988).
Sela, M., et. al., Conjugates of Antibodies with Cytotoxic Drugs, Immunoconjugates, pp. 189-216, (1987).
Shouval, D., et. al., Doxorubicin Conjugates of Monoclonal Antibodies to Hepatoma-Associated Antigens, Proc. Natl. Acad. Sci., vol. 85, pp. 8276-8280, (1988).
Tsukada, Y., et. al., An Anti-a-Fetoprotein Antibody-Daunorubicin Conjugate With a Novel Poly-L-Glutamic Acid Derivative as Intermediate Drug Carrier, J. Natl. Canc. Inst., vol. 73, No. 3, (1984), pp. 721-729.
Tsukada, Y., et. al., Suppression of Human a-Foetoprotein-Producing Hepatocellular Carcinoma Growth in Nude Mice by an Anti a-Foetoprotein Antibody-Daunorubicin Conjugate with a Poly-L-Glutamic Acid Derivatives as Intermediate Drug Carrier, Br. J. Cancer, (1985), vol. 52, pp. 111-116.
Ojima, I., et. al., Computational Analysis of the Paclitaxel Binding Site in a-Tubulin, American Chemical Society pp. 1, (2001), vol. 78.
Ojima, I, et. al., Design, Synthesis and Sar Studies of 3′ N Modified Second Generation Taxoids, American Chemical Society, pp. 1, (2001), vol. 78.
Ojima, I., et. al., Synthesis of Labeled Ligands for Solid State Nmr Studies of the Taxoids-Microtubule Interaction, American Chemical Society, pp. 1, (2001), vol. 78.
Ojima, I., et. al., Efficient Route to Triols and Polyols Via Rhodium-Catalyzed Intramolecular Silyformylation of Alkynes, American Chemical Society, pp. 1, (2001), vol. 78.

Affiliated with

Also associated with

Rating

Leptomycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Leptomycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leptomycin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4210825